Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2018 Jan;20(1):57-68.
doi: 10.1007/s12094-017-1783-2. Epub 2017 Nov 13.

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

J Cassinello  1 , J Á Arranz  2 , J M Piulats  3 , A Sánchez  4 , B Pérez-Valderrama  5 , B Mellado  6 , M Á Climent  7 , D Olmos  8 , J Carles  9 , M Lázaro  10
Affiliations
Practice Guideline

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

J Cassinello et al. Clin Transl Oncol. 2018 Jan.

Erratum in

Abstract

Androgen deprivation treatment was the only treatment available for metastatic prostate cancer until recently, with docetaxel as the only treatment with a proven survival benefit in castration-resistant prostate cancer (CRPC). Several drugs have been approved in the castration-resistant disease (sipuleucel-T, cabazitaxel, abiraterone, enzalutamide, radium-223). More recently, docetaxel and abiraterone have been moved to the hormone-sensitive disease setting, achieving better patient survival. The purpose of this article is to define the state of the art in the treatment of prostate carcinoma.

Keywords: Abiraterone; Androgen deprivation treatment; Cabazitaxel; Castration-resistant prostate cancer; Docetaxel; Enzalutamide; Hormone-sensitive advanced prostate cancer; Radium 223.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. EUCAN | Home page [Internet]. http://eco.iarc.fr/EUCAN/. Accessed 22 Jun 2017.
    1. Globocan 2012—Home [Internet]. http://globocan.iarc.fr/Default.aspx. Accessed 22 Jun 2017.
    1. Cassinello J, Climent MA, González del Alba A, Mellado B, Virizuela JA. Spanish Society for Medical Oncology. SEOM clinical guidelines for the treatment of metastatic prostate cancer. Clin Transl Oncol. 2014;16(12):1060–1066. doi: 10.1007/s12094-014-1225-3. - DOI - PMC - PubMed
    1. Dykewicz CA. Centers for Disease Control and Prevention (U.S.), Infectious Diseases Society of America, American Society of Blood and Marrow Transplantation. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis. 2001;33(2):139–144. doi: 10.1086/321805. - DOI - PubMed
    1. Cornford P, Bellmunt J, Bolla M, Briers E, De Santis M, Gross T, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2017;71(4):630–642. doi: 10.1016/j.eururo.2016.08.002. - DOI - PubMed

Publication types

Substances